(26 days)
The Nellcor Puritan Bennett Suzanne is intended for use in collecting and recording physiological data to be used in diagnosing sleep disorders. A pediatric through adult patient population is intended for the Suzanne, which can be used in either home or hospital environments.
The Suzanne System is composed of a data recorder that contains the electronics and software necessary to capture the physiological information of each sensor and to store this information in a Flash card or to send it to a computer via a serial communication port. The information that can be recorded by the Suzanne System is : - · EEG signals - · ECG signals - · Pressure signals - · Thoracic movements - Abdominal movements - Breath detection (through bucco-nasal thermistor) . - Flow (through pneumotachometer) - Envelope of ambient sound . - Body position . - Ambient light detection . - Arterial oxyhemoglobin saturation (SpO2) . - Pulse rate . The signals are amplified by different amplifiers contained in elements of the system known as headboxes. When used in a home environment, the data is recorded in the flash card and the clinician uses a setup unit to check that the system works correctly and to set the recording starting time. When used in a clinical environment, the system can be used as described above or data can be recorded to a computer with the use of a PC application software. The system is powered by an internal battery or by a DC power supply.
This document is a 510(k) summary for the Nellcor Puritan Bennett Suzanne Polysomnograph System. It describes the device, its intended use, and compares it to a legally marketed predicate device. The primary change in the modified device is the addition of new pulse oximetry technology. This document asserts that the modifications do not raise new questions of safety or effectiveness.
However, the provided document does not contain the detailed information required to answer your request about acceptance criteria and a study proving the device meets those criteria. Specifically, it lacks:
- A table of acceptance criteria and reported device performance.
- Information on sample sizes, data provenance, number of experts, adjudication methods, or ground truth for a test set.
- Details about multi-reader multi-case (MRMC) comparative effectiveness studies.
- Information on standalone algorithm performance.
- The type of ground truth used for a study.
- Sample size and ground truth establishment for a training set.
The document states that "Clinical and non-clinical tests were performed to support the determination of substantial equivalence" and that "The technological characteristics of the modified Suzanne and the results of clinical and non-clinical tests do not raise any new questions of safety or effectiveness when compared to the legally marketed (unmodified) device." However, it does not provide the specifics of these tests or their results.
Therefore, based solely on the provided text, I cannot complete your request. The document describes the regulatory submission process and the determination of substantial equivalence, but it does not detail the specific performance studies and their results.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo for Tyco Healthcare. The word "tyco" is in bold, black letters with a stylized "y". Below the word "tyco" is a horizontal line, and below that is the word "Healthcare" in a smaller, non-bold font. The logo is simple and professional.
'uritan Bennett
Nellcor Puritan Bennett (Meiville) 303 Terry Fox Drive Suite 400 Kanata, Ontario K2K 3J 1
Tele: 613 238-1840 Fax: 613 238-1291
MAR 2 4 2003
510(k) Summary
Submitter Information
Nellcor Puritan Bennett (Melville) Ltd. 400-303 Terry Fox Drive Kanata, Ontario K2K 3J1 Canada
Contact person
Rob Matheson Regulatory Affairs Associate Phone: 613-238-1840 ext. 288 Fax: 613-238-1291
Date Prepared:
February 24, 2003
Trade Name: Common Name: Classification Name: Classification Number:
Suzanne Portable Recording system Portable Polysomnographic Recorder Ventilatory Effort Recorder MNR-21CFR 868.2375
Predicate Devices
K990565 Suzanne Polysomnographic Recorder Nellcor Puritan Bennett K021090 N-550 Pulse Oximeter Nellcor Puritan Bennett
Proposed Device Description
The Suzanne System is composed of a data recorder that contains the electronics and software necessary to capture the physiological information of each sensor and to store this information in a Flash card or to send it to a computer via a serial communication port.
The information that can be recorded by the Suzanne System is :
- · EEG signals
- · ECG signals
- · Pressure signals
- · Thoracic movements
{1}------------------------------------------------
- Abdominal movements
- Breath detection (through bucco-nasal thermistor) .
- Flow (through pneumotachometer)
- Envelope of ambient sound .
- Body position .
- Ambient light detection .
- Arterial oxyhemoglobin saturation (SpO2) .
- Pulse rate .
The signals are amplified by different amplifiers contained in elements of the system known as headboxes. When used in a home environment, the data is recorded in the flash card and the clinician uses a setup unit to check that the system works correctly and to set the recording starting time.
When used in a clinical environment, the system can be used as described above or data can be recorded to a computer with the use of a PC application software.
The system is powered by an internal battery or by a DC power supply.
Intended Use
The Nellcor Puritan Bennett Suzanne is intended for use in collecting and recording physiological data to be used in diagnosing sleep disorders.
A pediatric through adult patient population is intended for the Suzanne, which can be used in either home or hospital environments.
Summary of Technological Characteristics of the Device Compared to the Legally Marketed (Unmodified) Device
The proposed Suzanne has the same technological characteristics as the above referenced predicate device, the unmodified Suzanne. The proposed version of the device has been modified by adding new pulse oximetry technology.
Tests Performed to Support Determination of Substantial Equivalence
Clinical and non-clinical tests were performed to support the determination of substantial equivalence.
Conclusions
The technological characteristics of the modified Suzanne and the results of clinical and non-clinical tests do not raise any new questions of safety or effectiveness when compared to the legally marketed (unmodified) device.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure, with its wings represented by three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 4 2003
Mr. Rob Matheson Regulatory Affairs Associate Nellcor Puritan Bennett (Melville) Limited 400-303 Terry Fox Drive Kanata. Ontario K2K 3J1 CANADA
Re: K030611
Trade/Device Name: Suzanne Polysomnograph System Regulation Number: 868.2375 Regulation Name: Breathing Frequency Monitor Regulatory Class: II Product Code: MNR Dated: February 25, 2003 Received: February 26, 2003
Dear Mr. Matheson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Mr. Matheson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours
Susan Runore
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
510(k) Number (if known): _______________
Device Name: Suzanne Polysomnograph System
Indications for Use:
The Nellcor Puritan Bennett Suzanne is intended for use in collecting and recording physiological data to be used in diagnosing sleep disorders.
A pediatric through adult patient population is intended for the Suzanne, which can be used in either home or hospital environments.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Optional Format 3-10-98)
510(k) Number K030611
§ 868.2375 Breathing frequency monitor.
(a)
Identification. A breathing (ventilatory) frequency monitor is a device intended to measure or monitor a patient's respiratory rate. The device may provide an audible or visible alarm when the respiratory rate, averaged over time, is outside operator settable alarm limits. This device does not include the apnea monitor classified in § 868.2377.(b)
Classification. Class II (performance standards).